Ignite Creation Date:
2024-05-05 @ 5:21 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00431262
Status:
UNKNOWN
Last Update Posted:
2007-03-05
First Post:
2007-02-01
Brief Title:
Antabuse in Severe Alcoholism an Open Controlled Study
Sponsor:
Psykiatrisk Center Gentofte
Organization:
Psykiatrisk Center Gentofte
Study Overview
Official Title:
Antabuse in Severe Alcoholism an Open Controlled Study
Status:
UNKNOWN
Status Verified Date:
2007-03
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Newly detoxified alcoholics N60 are randomised to either antabuse disulfiram treatment or the control group for a total of 6 monthsAll patients will receive cognitive behavioural treatment in groups The hypothesis to be tested is that more of the patients who receive antabuse disulfiram will be alcohol free during the 6 months treatment period compared to the control group The trial is open
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None